Novartis Spinoff Of Sandoz Generic And Biosimilars Business Set For October 4
Novartis (NVS) is not new to these hallowed pages. Longtime readers (and we appreciate you not pointing out our long absence) will recall that Novartis spun off Alcon(ALC) in April 2019. Last week, however, Novartis completed one of the final steps in its upcoming Sandoz(SDZ) spinoff. At a (fairly ordinary) extraordinary shareholder meeting on September 15, 2023, Novartis… Read More »